Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

May 2013 - FRMC

Department

Conference Insider
05/17/2013

Jill Sederstrom

Jill Sederstrom
San Diego—Medication nonadherence is a costly problem in healthcare, but predictive modeling, value-based insurance design (VBID), and the application of gamification could help improve adherence rates. These 3 strategies and the challenges...
San Diego—Medication nonadherence is a costly problem in healthcare, but predictive modeling, value-based insurance design (VBID), and the application of gamification could help improve adherence rates. These 3 strategies and the challenges...
San Diego—Medication...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013

Tim Casey

Tim Casey
San Diego—As many as 6 million people in the United States are at risk of anaphylaxis, and the prevalence is increasing, especially among people <20 years of age, according to several studies. In August 2012, the FDA approved Auvi-Q™...
San Diego—As many as 6 million people in the United States are at risk of anaphylaxis, and the prevalence is increasing, especially among people <20 years of age, according to several studies. In August 2012, the FDA approved Auvi-Q™...
San Diego—As many as 6 million...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013

Tori Socha

Tori Socha
San Diego—There are approximately 7000 diseases that are categorized as rare, but only 5% of those have approved treatments. The 1984 amendment to the Orphan Drug Act of 1983 (ODA) defined a rare disease as one that affects 200,000 people in...
San Diego—There are approximately 7000 diseases that are categorized as rare, but only 5% of those have approved treatments. The 1984 amendment to the Orphan Drug Act of 1983 (ODA) defined a rare disease as one that affects 200,000 people in...
San Diego—There are...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013

Tim Casey

Tim Casey
San Diego—With major provisions from the Patient Protection and Affordable Care Act becoming effective next year, the healthcare industry is facing a challenge keeping medication costs in check due to, in part, the proliferation of expensive...
San Diego—With major provisions from the Patient Protection and Affordable Care Act becoming effective next year, the healthcare industry is facing a challenge keeping medication costs in check due to, in part, the proliferation of expensive...
San Diego—With major provisions...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013

Mary Beth Nierengarten

Mary Beth Nierengarten
San Diego—With the dominance of specialty drugs driving increasing prescription medication expenditures, pharmacists need to prepare for significant growth in specialty pharmaceuticals and its impact on medication benefit plans.
San Diego—With the dominance of specialty drugs driving increasing prescription medication expenditures, pharmacists need to prepare for significant growth in specialty pharmaceuticals and its impact on medication benefit plans.
San Diego—With the dominance of...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013

Tori Socha

Tori Socha
San Diego—Pain is challenging to treat and the healthcare cost burden of pain is substantial. According to researchers, understanding the dynamics of the economic burden of pain will help providers and payers allocate resources more...
San Diego—Pain is challenging to treat and the healthcare cost burden of pain is substantial. According to researchers, understanding the dynamics of the economic burden of pain will help providers and payers allocate resources more...
San Diego—Pain is challenging to...
05/17/2013
First Report Managed Care
Conference Insider
05/17/2013

Tori Socha

Tori Socha
San Diego—Multiple sclerosis generally presents in young adults, resulting in a greater loss of productivity and quality of life compared with other diseases. Frequency of relapses can be reduced with use of disease-modifying drugs (DMDs),...
San Diego—Multiple sclerosis generally presents in young adults, resulting in a greater loss of productivity and quality of life compared with other diseases. Frequency of relapses can be reduced with use of disease-modifying drugs (DMDs),...
San Diego—Multiple sclerosis...
05/17/2013
First Report Managed Care
Department
05/17/2013

Tim Casey

Tim Casey
San Diego—In the past, patients with multiple sclerosis were required to administer medications intravenously or via injections, a painful process for some, but they had no other choices. Now, though, treatment options have expanded into oral...
San Diego—In the past, patients with multiple sclerosis were required to administer medications intravenously or via injections, a painful process for some, but they had no other choices. Now, though, treatment options have expanded into oral...
San Diego—In the past, patients...
05/17/2013
First Report Managed Care
05/17/2013

Tori Socha

Tori Socha
San Diego—In March 2012, the U.S. Department of Health & Human Services (HHS) issued guidelines for the use of antiretroviral therapy (ART) in patients with HIV that recommend 4 specific preferred ART regimens for ART-naïve patients.
San Diego—In March 2012, the U.S. Department of Health & Human Services (HHS) issued guidelines for the use of antiretroviral therapy (ART) in patients with HIV that recommend 4 specific preferred ART regimens for ART-naïve patients.
San Diego—In March 2012, the...
05/17/2013
First Report Managed Care
05/17/2013

Tori Socha

Tori Socha
San Diego—Healthcare decision makers face challenges in optimizing disease management in patients with type 2 diabetes mellitus (T2DM). Increasing healthcare expenditures can be attributed, in part, to the costs, including medical and...
San Diego—Healthcare decision makers face challenges in optimizing disease management in patients with type 2 diabetes mellitus (T2DM). Increasing healthcare expenditures can be attributed, in part, to the costs, including medical and...
San Diego—Healthcare decision...
05/17/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement